In contrast, apolipoprotein B (ApoB) levels and the ApoB/ApoA1 ratio were both significantly elevated in the T1DM group (p = 0.0103 and p = 0.0316, respectively), indicating a pro-atherogenic lipid profile and increased cardiovascular risk. This evidence concerns the gene APOA1 and type 1 diabetes mellitus.